PTGS2 and coronary artery disorder: Furthermore, studies have shown[32] that overexpression of PTGS1 and PTGS2 can lead to excessive platelet activation, increasing the risk of thrombosis, causing vasoconstriction, and reducing blood flow,[31,33] thereby impacting the onset and prognosis of CHD in multiple ways.